home / stock / tmbr / tmbr quote
Last: | $0.3426 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.3426 |
High: | $0 |
Low: | $0 |
Volume: | 26,307 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.3426 | $0 | $0.3426 | $0 | $0 | 26,307 | 11-29-2023 |
$0.3426 | $0.3411 | $0.3426 | $0.35 | $0.3202 | 292,020 | 11-28-2023 |
$0.3401 | $0.3589 | $0.3401 | $0.37 | $0.3303 | 263,509 | 11-27-2023 |
$0.37 | $0.38 | $0.37 | $0.3854 | $0.351 | 206,270 | 11-24-2023 |
$0.36 | $0.48 | $0.36 | $0.48 | $0.36 | 848,043 | 11-23-2023 |
$0.36 | $0.48 | $0.36 | $0.48 | $0.36 | 836,377 | 11-22-2023 |
$0.4168 | $0.9609 | $0.4168 | $0.9609 | $0.3336 | 2,633,978 | 11-21-2023 |
$1.4609 | $1.58 | $1.4609 | $1.78 | $1.4151 | 248,858 | 11-17-2023 |
$1.25 | $2.34 | $1.25 | $2.36 | $1.25 | 217,549 | 11-16-2023 |
$2.34 | $2.36 | $2.34 | $2.47 | $2.27 | 84,126 | 11-15-2023 |
$2.42 | $2.41 | $2.42 | $2.49 | $2.41 | 54,484 | 11-14-2023 |
$2.42 | $2.46 | $2.42 | $2.5 | $2.3897 | 71,783 | 11-13-2023 |
$2.55 | $2.56 | $2.55 | $2.57 | $2.515 | 7,519 | 11-10-2023 |
$2.5 | $2.55 | $2.5 | $2.55 | $2.5 | 4,152 | 11-09-2023 |
$2.54 | $2.5 | $2.54 | $2.54 | $2.4601 | 21,033 | 11-08-2023 |
$2.46 | $2.51 | $2.46 | $2.57 | $2.4501 | 16,378 | 11-07-2023 |
$2.51 | $2.45 | $2.51 | $2.59 | $2.45 | 21,294 | 11-06-2023 |
$2.51 | $2.46 | $2.51 | $2.5571 | $2.44 | 17,991 | 11-03-2023 |
$2.5 | $2.38 | $2.5 | $2.5 | $2.38 | 25,035 | 11-02-2023 |
$2.38 | $2.51 | $2.38 | $2.575 | $2.2775 | 79,933 | 11-01-2023 |
News, Short Squeeze, Breakout and More Instantly...
Timber Pharmaceuticals Inc. Company Name:
TMBR Stock Symbol:
NYSE Market:
Timber Pharmaceuticals Inc. Website:
WARREN, N.J., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Timber Pharmaceuticals, Inc. ("Timber" or the "Company") (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that...
WARREN, NJ - ( NewMediaWire ) - November 28, 2023 - Timber Pharmaceuticals, Inc. (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, and its affiliated debtors and debtor-...
WARREN, NJ, Nov. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, and its affiliated d...